Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Andrew Menzies-Gow, Jason Steenkamp, Sumeet Singh, Wilma Erhardt, Jennifer Rowell, Pallavi Rane, Neil Martin, Jean Pierre Llanos & Anna Quinton. (2022) Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison. Journal of Medical Economics 25:1, pages 679-690.
Read now
Read now
Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Paola Rogliani, Pierachille Santus, Claudia Pitotti, Sergio Di Matteo, Chiara Martinotti & Giacomo Matteo Bruno. (2020) Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study. Risk Management and Healthcare Policy 13, pages 43-53.
Read now
Read now
Jean-Pierre Llanos, Christopher F Bell, Elizabeth Packnett, Ellen Thiel, Debra E Irwin, Beth Hahn & Hector Ortega. (2019) Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. Journal of Asthma and Allergy 12, pages 43-58.
Read now
Read now
Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, Diego Bagnasco & Enrico Heffler. (2019) Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?. Expert Opinion on Biological Therapy 19:7, pages 601-606.
Read now
Read now
Jaymin B Morjaria, Rosalia Emma, Virginia Fuochi, Riccardo Polosa & Massimo Caruso. (2019) An evaluation of mepolizumab for the treatment of severe asthma. Expert Opinion on Biological Therapy 19:6, pages 491-500.
Read now
Read now
Khalid Al Efraij & J. Mark FitzGerald. (2018) Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype. Expert Review of Clinical Pharmacology 11:7, pages 669-676.
Read now
Read now
Articles from other publishers (15)
Şeyma Özden, Fatma Merve Tepetam, Cihan Örçen & Tuğçe Yakut. (2023) The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab–mepolizumab treatment efficiency in these patients. Medicine 102:43, pages e35247.
Crossref
Crossref
Francisco Casas-Maldonado, Francisco-Javier Álvarez-Gutiérrez, Marina Blanco Aparicio, Christian Domingo Ribas, Carolina Cisneros Serrano, Gregorio Soto Campos, Berta Román Bernal & Francisco-Javier González-Barcala. (2023) Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain. Open Respiratory Archives 5:3, pages 100252.
Crossref
Crossref
Fatma Merve Tepetam, Ali Burkan Akyildiz, Şeyma Özden, Cihan Örcen, Tuğçe YakutÖzge Atik. (2023) Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic “Overlap” severe asthma: Biological agent preference in atopic-eosinophilic severe asthma. Medicine 102:18, pages e33660.
Crossref
Crossref
Iain Crossingham, Rebekah Richardson, Timothy SC Hinks, Sally Spencer, Simon Couillard, Anne-Catherine Maynard-Paquette, Doranne Thomassen & Imran Howell. (2022) Biologics for chronic severe asthma: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:10.
Crossref
Crossref
Sandrah P. Eckel, Erika Garcia & Frank D. Gilliland. (2022)
Predicting asthma exacerbations: is there utility in noninvasive assessment of distal airway inflammation using multiple flow
F
ENO
?
. European Respiratory Journal 60:3, pages 2200802.
Crossref
Crossref
Armando Partida-Gaytán, Luis Torre-Bouscoulet, Marco Polo Macías, Alejandro Raimondi & Emilio Pizzichini. (2021) Mepolizumab para el tratamiento de asma grave eosinofílica. Revista Alergia México 67.
Crossref
Crossref
Gabriel García, Miguel Bergna, Juan C. Vásquez, Maria C. Cano Salas, José L. Miguel, Carlos Celis Preciado, Agustin Acuña Izcaray, Manuel Barros Monge, Natalia García Batista, Ignacio Zabert, José L. Mayorga, Renato Casanova Mendoza, Martha Gutierrez, Maria F. Montero Arias, Luzcenelia Urtecho Perez, Miguel Antúnez, Victoria Williams Derby, Alejandra Villatoro Azméquita, Luis Motiño, M. Alenita De Oliveira, Diana Rey Sanchez, Marisol Arroyo & Mario Rodriguez. (2021) Severe asthma: adding new evidence – Latin American Thoracic Society. ERJ Open Research 7:1, pages 00318-2020.
Crossref
Crossref
Lorenzo S Petralia, Anisha Bahl, Rob Peverall, Graham Richmond, John H Couper, Gus Hancock, Peter A Robbins & Grant A D Ritchie. (2020)
Accurate real-time F
E
NO expirograms using complementary optical sensors
. Journal of Breath Research 14:4, pages 047102.
Crossref
Crossref
Anna Książkiewicz, Edyta Kwilosz, Rafał Fornal & Ewa Dworzańska. (2020) Management and treatment of bronchial asthma in adults and children on the basis of new guidelines. Postępy Higieny i Medycyny Doświadczalnej 74, pages 283-300.
Crossref
Crossref
Andras Bikov, Ipek Kivilcim Oğuzülgen, Ilaria Baiardini, Marco Contoli, Alexander Emelyanov, Omar Fassio, Juan Carlos Ivancevich, Igor Kaidashev, Krzysztof Kowal, Marina Labor, Lies Lahousse, Stefan Mihaicuta, Silviya Novakova, Alicia Padilla Galo, Alexander Simidchiev, Angelica Tiotiu, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Nelson Rosario, Pierachille Santus, Fulvio Braido, Carmen Ardelean, Hector Badellino, Ariel Blua, Antonio Castillo, E. Carpagnano Giovanna, J. Chong-Neto Herberto, F. Daniel Colodenco, Dario Md Colombaro, Jaime Correia-De-Sousa, Fabiano Di Marco, Kunio Dobashi, Rocio Garcia, René Maximiliano Gomez, Olecsandr Gopko, Guillermo Guidos, Martina Hajduk, Joanna Hermanowicz-Salamon, Enrico Heffler, Bulent Karadag, Ali F. Kalyoncu, Metin Keren, Lykorguos Kolilekas, Marcelina Kocwin, Borislava Krusheva, Désirée Larenas Linnemann, Irine Litovchenko, A. Marcipar, L.E. Meza, D. Nedeva, P. Novakova, D. Plavec, S. Popović-Grle, F. Puggioni, L. Pur Oziygit, N. Rodrigez, D. Ryan, I. Ruzsics, N. Scichilone, F. Serpa, P. Steiropoulos, P. Solidoro, M. Turkalj, T. Umanets, C.F. Victorio, J.M. Zubeldia, V. Yachnyk & M. Zitt. (2020) Beliefs and preferences regarding biological treatments for severe asthma. World Allergy Organization Journal 13:7, pages 100441.
Crossref
Crossref
Mattia Giovannini, Francesca Mori, Simona Barni, Maurizio de Martino & Elio Novembre. (2019) Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?. Italian Journal of Pediatrics 45:1.
Crossref
Crossref
Ioana Agache. (2019) Severe asthma phenotypes and endotypes. Seminars in Immunology 46, pages 101301.
Crossref
Crossref
Shuko Hirota, Yoichi Kobayashi, Takashi Ishiguro, Takashi Nishida, Naho Kagiyama, Yoshihiko Shimizu & Noboru Takayanagi. (2019) Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature. Respiratory Medicine Case Reports 26, pages 59-62.
Crossref
Crossref
Ioana Agache, Catalina Cojanu & Liliana Rogozea. 2019. Implementing Precision Medicine in Best Practices of Chronic Airway Diseases. Implementing Precision Medicine in Best Practices of Chronic Airway Diseases
45
49
.
Ioana Agache & Liliana Rogozea. (2018) Endotypes in allergic diseases. Current Opinion in Allergy & Clinical Immunology 18:3, pages 177-183.
Crossref
Crossref